Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis
Multiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS a...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.635257/full |
id |
doaj-89f198f720cb45c3934a7836314531e9 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luisa F. Duarte Luisa F. Duarte María J. Altamirano-Lagos María J. Altamirano-Lagos Jorge H. Tabares-Guevara Jorge H. Tabares-Guevara Ma. Cecilia Opazo Ma. Cecilia Opazo Máximo Díaz Máximo Díaz Romina Navarrete Romina Navarrete Catalina Muza Catalina Muza Omar P. Vallejos Omar P. Vallejos Claudia A. Riedel Claudia A. Riedel Susan M. Bueno Susan M. Bueno Alexis M. Kalergis Alexis M. Kalergis Alexis M. Kalergis Pablo A. González Pablo A. González |
spellingShingle |
Luisa F. Duarte Luisa F. Duarte María J. Altamirano-Lagos María J. Altamirano-Lagos Jorge H. Tabares-Guevara Jorge H. Tabares-Guevara Ma. Cecilia Opazo Ma. Cecilia Opazo Máximo Díaz Máximo Díaz Romina Navarrete Romina Navarrete Catalina Muza Catalina Muza Omar P. Vallejos Omar P. Vallejos Claudia A. Riedel Claudia A. Riedel Susan M. Bueno Susan M. Bueno Alexis M. Kalergis Alexis M. Kalergis Alexis M. Kalergis Pablo A. González Pablo A. González Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis Frontiers in Immunology HSV-1 viral infection multiple sclerosis experimental autoimmune encephalomyelitis neuroinflammation |
author_facet |
Luisa F. Duarte Luisa F. Duarte María J. Altamirano-Lagos María J. Altamirano-Lagos Jorge H. Tabares-Guevara Jorge H. Tabares-Guevara Ma. Cecilia Opazo Ma. Cecilia Opazo Máximo Díaz Máximo Díaz Romina Navarrete Romina Navarrete Catalina Muza Catalina Muza Omar P. Vallejos Omar P. Vallejos Claudia A. Riedel Claudia A. Riedel Susan M. Bueno Susan M. Bueno Alexis M. Kalergis Alexis M. Kalergis Alexis M. Kalergis Pablo A. González Pablo A. González |
author_sort |
Luisa F. Duarte |
title |
Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis |
title_short |
Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis |
title_full |
Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis |
title_fullStr |
Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis |
title_full_unstemmed |
Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune Encephalomyelitis |
title_sort |
asymptomatic herpes simplex virus type 1 infection causes an earlier onset and more severe experimental autoimmune encephalomyelitis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-02-01 |
description |
Multiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS and the identification of novel therapies to treat its symptoms, the etiology of this disease remains unknown. However, recent studies have suggested that viral infections may contribute to disease onset. Interestingly, a potential association between herpes simplex virus type 1 (HSV-1) infection and MS has been reported, yet a direct relationship among both has not been conclusively demonstrated. Experimental autoimmune encephalomyelitis (EAE) recapitulates several aspects of MS in humans and is widely used to study this disease. Here, we evaluated the effect of asymptomatic brain infection by HSV-1 on the onset and severity of EAE in C57BL/6 mice. We also evaluated the effect of infection with an HSV-1-mutant that is attenuated in neurovirulence and does not cause encephalitis. Importantly, we observed more severe EAE in mice previously infected either, with the wild-type (WT) or the mutant HSV-1, as compared to uninfected control mice. Also, earlier EAE onset was seen after WT virus inoculation. These findings support the notion that a previous exposure to HSV-1 can accelerate and enhance EAE, which suggests a potential contribution of asymptomatic HSV-1 to the onset and severity of MS. |
topic |
HSV-1 viral infection multiple sclerosis experimental autoimmune encephalomyelitis neuroinflammation |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2021.635257/full |
work_keys_str_mv |
AT luisafduarte asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT luisafduarte asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT mariajaltamiranolagos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT mariajaltamiranolagos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT jorgehtabaresguevara asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT jorgehtabaresguevara asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT maceciliaopazo asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT maceciliaopazo asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT maximodiaz asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT maximodiaz asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT rominanavarrete asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT rominanavarrete asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT catalinamuza asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT catalinamuza asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT omarpvallejos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT omarpvallejos asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT claudiaariedel asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT claudiaariedel asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT susanmbueno asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT susanmbueno asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT alexismkalergis asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT alexismkalergis asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT alexismkalergis asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT pabloagonzalez asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis AT pabloagonzalez asymptomaticherpessimplexvirustype1infectioncausesanearlieronsetandmoresevereexperimentalautoimmuneencephalomyelitis |
_version_ |
1724269202041208832 |
spelling |
doaj-89f198f720cb45c3934a7836314531e92021-02-15T04:50:02ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-02-011210.3389/fimmu.2021.635257635257Asymptomatic Herpes Simplex Virus Type 1 Infection Causes an Earlier Onset and More Severe Experimental Autoimmune EncephalomyelitisLuisa F. Duarte0Luisa F. Duarte1María J. Altamirano-Lagos2María J. Altamirano-Lagos3Jorge H. Tabares-Guevara4Jorge H. Tabares-Guevara5Ma. Cecilia Opazo6Ma. Cecilia Opazo7Máximo Díaz8Máximo Díaz9Romina Navarrete10Romina Navarrete11Catalina Muza12Catalina Muza13Omar P. Vallejos14Omar P. Vallejos15Claudia A. Riedel16Claudia A. Riedel17Susan M. Bueno18Susan M. Bueno19Alexis M. Kalergis20Alexis M. Kalergis21Alexis M. Kalergis22Pablo A. González23Pablo A. González24Millennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Ciencias Biológicas, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileDepartamento de Endocrinología, Facultad de Medicina, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, ChileMillennium Institute on Immunology and Immunotherapy, Santiago, ChileDepartamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, ChileMultiple sclerosis (MS) is an increasingly prevalent progressive autoimmune and debilitating chronic disease that involves the detrimental recognition of central nervous system (CNS) antigens by the immune system. Although significant progress has been made in the last decades on the biology of MS and the identification of novel therapies to treat its symptoms, the etiology of this disease remains unknown. However, recent studies have suggested that viral infections may contribute to disease onset. Interestingly, a potential association between herpes simplex virus type 1 (HSV-1) infection and MS has been reported, yet a direct relationship among both has not been conclusively demonstrated. Experimental autoimmune encephalomyelitis (EAE) recapitulates several aspects of MS in humans and is widely used to study this disease. Here, we evaluated the effect of asymptomatic brain infection by HSV-1 on the onset and severity of EAE in C57BL/6 mice. We also evaluated the effect of infection with an HSV-1-mutant that is attenuated in neurovirulence and does not cause encephalitis. Importantly, we observed more severe EAE in mice previously infected either, with the wild-type (WT) or the mutant HSV-1, as compared to uninfected control mice. Also, earlier EAE onset was seen after WT virus inoculation. These findings support the notion that a previous exposure to HSV-1 can accelerate and enhance EAE, which suggests a potential contribution of asymptomatic HSV-1 to the onset and severity of MS.https://www.frontiersin.org/articles/10.3389/fimmu.2021.635257/fullHSV-1viral infectionmultiple sclerosisexperimental autoimmune encephalomyelitisneuroinflammation |